86 related articles for article (PubMed ID: 15800927)
1. E1A-F is overexpressed early in human colorectal neoplasia and associated with cyclooxygenase-2 and matrix metalloproteinase-7.
Boedefeld WM; Soong R; Weiss H; Diasio RB; Urist MM; Bland KI; Heslin MJ
Mol Carcinog; 2005 May; 43(1):13-7. PubMed ID: 15800927
[TBL] [Abstract][Full Text] [Related]
2. Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer.
Horiuchi S; Yamamoto H; Min Y; Adachi Y; Itoh F; Imai K
J Pathol; 2003 Aug; 200(5):568-76. PubMed ID: 12898592
[TBL] [Abstract][Full Text] [Related]
3. Interplay of insulin-like growth factor-II, insulin-like growth factor-I, insulin-like growth factor-I receptor, COX-2, and matrix metalloproteinase-7, play key roles in the early stage of colorectal carcinogenesis.
Nosho K; Yamamoto H; Taniguchi H; Adachi Y; Yoshida Y; Arimura Y; Endo T; Hinoda Y; Imai K
Clin Cancer Res; 2004 Dec; 10(23):7950-7. PubMed ID: 15585629
[TBL] [Abstract][Full Text] [Related]
4. Association of Ets-related transcriptional factor E1AF expression with overexpression of matrix metalloproteinases, COX-2 and iNOS in the early stage of colorectal carcinogenesis.
Nosho K; Yoshida M; Yamamoto H; Taniguchi H; Adachi Y; Mikami M; Hinoda Y; Imai K
Carcinogenesis; 2005 May; 26(5):892-9. PubMed ID: 15695237
[TBL] [Abstract][Full Text] [Related]
5. Early expression of cyclo-oxygenase-2 during sporadic colorectal carcinogenesis.
Hao X; Bishop AE; Wallace M; Wang H; Willcocks TC; Maclouf J; Polak JM; Knight S; Talbot IC
J Pathol; 1999 Feb; 187(3):295-301. PubMed ID: 10398082
[TBL] [Abstract][Full Text] [Related]
6. Molecular basis of colorectal cancer - role of gastrin and cyclooxygenase-2.
Hartwich J; Konturek SJ; Pierzchalski P; Zuchowicz M; Konturek PC; Bielański W; Marlicz K; Starzyńska T; Ławniczak M
Med Sci Monit; 2001; 7(6):1171-81. PubMed ID: 11687726
[TBL] [Abstract][Full Text] [Related]
7. Fecal cyclooxygenase 2 plus matrix metalloproteinase 7 mRNA assays as a marker for colorectal cancer screening.
Takai T; Kanaoka S; Yoshida K; Hamaya Y; Ikuma M; Miura N; Sugimura H; Kajimura M; Hishida A
Cancer Epidemiol Biomarkers Prev; 2009 Jun; 18(6):1888-93. PubMed ID: 19505922
[TBL] [Abstract][Full Text] [Related]
8. Nuclear factor-kappa B regulates cyclooxygenase-2 expression and cell proliferation in human colorectal carcinoma tissue.
Yu LL; Yu HG; Yu JP; Luo HS
Eksp Onkol; 2004 Mar; 26(1):40-7. PubMed ID: 15112579
[TBL] [Abstract][Full Text] [Related]
9. Subepithelial myofibroblasts express cyclooxygenase-2 in colorectal tubular adenomas.
Adegboyega PA; Ololade O; Saada J; Mifflin R; Di Mari JF; Powell DW
Clin Cancer Res; 2004 Sep; 10(17):5870-9. PubMed ID: 15355919
[TBL] [Abstract][Full Text] [Related]
10. Expression of 15-lipoxygenase-1 in human colorectal cancer.
Ikawa H; Kamitani H; Calvo BF; Foley JF; Eling TE
Cancer Res; 1999 Jan; 59(2):360-6. PubMed ID: 9927047
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase-7 expression in colorectal cancer liver metastases: evidence for involvement of MMP-7 activation in human cancer metastases.
Zeng ZS; Shu WP; Cohen AM; Guillem JG
Clin Cancer Res; 2002 Jan; 8(1):144-8. PubMed ID: 11801551
[TBL] [Abstract][Full Text] [Related]
12. Human colorectal adenomas demonstrate a size-dependent increase in epithelial cyclooxygenase-2 expression.
Elder DJ; Baker JA; Banu NA; Moorghen M; Paraskeva C
J Pathol; 2002 Dec; 198(4):428-34. PubMed ID: 12434411
[TBL] [Abstract][Full Text] [Related]
13. Association between Cyclooxygenase expression and colorectal adenoma characteristics.
Einspahr JG; Krouse RS; Yochim JM; Danenberg PV; Danenberg KD; Bhattacharyya AK; Martínez ME; Alberts DS
Cancer Res; 2003 Jul; 63(14):3891-3. PubMed ID: 12873979
[TBL] [Abstract][Full Text] [Related]
14. Tumor epithelial cell matrix metalloproteinase 9 is a target for antimetastatic therapy in colorectal cancer.
Lubbe WJ; Zhou ZY; Fu W; Zuzga D; Schulz S; Fridman R; Muschel RJ; Waldman SA; Pitari GM
Clin Cancer Res; 2006 Mar; 12(6):1876-82. PubMed ID: 16551873
[TBL] [Abstract][Full Text] [Related]
15. Cyclooxygenase-2 expression is associated with increased size in human sporadic colorectal adenomas.
Pisano C; Ottaiano A; Tatangelo F; Di Bonito M; Falanga M; Iaffaioli VR; Botti G; Pignata S; Acquaviva AM
Anticancer Res; 2005; 25(3B):2065-8. PubMed ID: 16158946
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological assessment and quantitative estimation of the matrix metalloproteinases MMP-2 and MMP-7 and the inhibitors TIMP-1 and TIMP-2 in colorectal carcinoma tissue samples.
Pesta M; Topolcan O; Holubec L; Rupert K; Cerna M; Holubec LS; Treska V; Finek J; Cerny R
Anticancer Res; 2007; 27(4A):1863-7. PubMed ID: 17649785
[TBL] [Abstract][Full Text] [Related]
17. Association of E1AF mRNA expression with tumor progression and matrilysin in human rectal cancer.
Liu HY; Zhou B; Wang L; Li Y; Zhou ZG; Sun XF; Xu B; Zeng YJ; Song JM; Luo HZ; Yang L
Oncology; 2007; 73(5-6):384-8. PubMed ID: 18511876
[TBL] [Abstract][Full Text] [Related]
18. Differential stromal and epithelial localization of cyclooxygenase-2 (COX-2) during colorectal tumorigenesis.
Arnoletti JP; Upson J; Babb JS; Bellacosa A; Watson JC
J Exp Clin Cancer Res; 2005 Jun; 24(2):279-87. PubMed ID: 16110762
[TBL] [Abstract][Full Text] [Related]
19. Rofecoxib regulates the expression of genes related to the matrix metalloproteinase pathway in humans: implication for the adverse effects of cyclooxygenase-2 inhibitors.
Wang XM; Wu TX; Lee YS; Dionne RA
Clin Pharmacol Ther; 2006 Apr; 79(4):303-15. PubMed ID: 16580899
[TBL] [Abstract][Full Text] [Related]
20. Study of cyclooxygenase-2 in renal cell carcinoma.
Yoshimura R; Matsuyama M; Kawahito Y; Tsuchida K; Kuratsukuri K; Takemoto Y; Mitsuhashi M; Sano H; Nakatani T
Int J Mol Med; 2004 Feb; 13(2):229-33. PubMed ID: 14719128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]